x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- Ishikane, MasahiroRemove Ishikane, Masahiro filter
- 2022 - 2023Remove 2022 - 2023 filter
Coronavirus (COVID-19) Collection
2 Results
- Case ReportOpen Access
Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection
International Journal of Infectious DiseasesVol. 119p18–20Published online: March 16, 2022- Makoto Inada
- Masahiro Ishikane
- Mari Terada
- Akihiro Matsunaga
- Kenji Maeda
- Noriko Iwamoto
- and others
Cited in Scopus: 0Since December 2019, COVID-19 caused by SARS-CoV-2 has spread worldwide (Hayakawa et al., 2020). As of January 25th, 2022, 544 re-infected COVID-19 cases have been reported worldwide (BNO news. 2022; Inada et al., 2021). - PerspectivesOpen Access
Antimicrobial Use Fell Substantially in Japan in 2020—The COVID-19 Pandemic May Have Played a Role
International Journal of Infectious DiseasesVol. 119p13–17Published online: March 16, 2022- Akane Ono
- Ryuji Koizumi
- Shinya Tsuzuki
- Yusuke Asai
- Masahiro Ishikane
- Yoshiki Kusama
- and others
Cited in Scopus: 1The COVID-19 outbreak in China at the end of 2019 had spread to Japan by early 2020. The surge in infected cases may have precipitated behavioral changes among physicians and patients, including increased unnecessary antimicrobial use (AU) that could promote antimicrobial resistance (AMR).